Q4 Medicine
Karolina Michałowska, Emil Bartosz Rozenek, Alicja Cichocka, Bogumiła Szewczak, B. Król, N. Waszkiewicz
{"title":"Omówienie wybranych metod współczesnej terapii schizofrenii","authors":"Karolina Michałowska, Emil Bartosz Rozenek, Alicja Cichocka, Bogumiła Szewczak, B. Król, N. Waszkiewicz","doi":"10.5603/psych.a2021.0027","DOIUrl":null,"url":null,"abstract":"Schizophrenia is a mental disorder with a complex etiopathogenesis explained by several still developing theories. Knowledge of these theories can matter when choosing the right treatment, because it increases the chance of therapeutic success. Various strategies are currently being developed so that we can, to some extent, adapt therapy to the individual needs of patients and, thus, optimize the therapeutic effect and minimize side effects. The issue of personalization of therapy translates into better cooperation between the doctor and the patient. The involvement of both parts in the treatment process, as in the treatment of other mental disorders, is crucial for its effectiveness. \nThe therapeutic methods that we have at our disposal are still not producing satisfactory results in reducing the negative symptoms or cognitive disorders that occur in schizophrenia. Currently, not only the development of psychiatry but also development of certain branches of science related to medicine, such as pharmacogenetics and molecular biology, can contribute to achieving satisfactory research results. It therefore seems reasonable to seek new treatment strategies. A brief presentation of the most promising therapeutic methods is the aim of this literature review. It covers pharmacological treatment (cariprazine, lurasidone, lumateperone, paliperidone), transcranial magnetic stimulation (TMS), psychotherapy and cognitive enhancement therapy (CET). The issue of pharmacogenetics of schizophrenia was also raised.","PeriodicalId":39960,"journal":{"name":"Psychiatria","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/psych.a2021.0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

精神分裂症是一种具有复杂发病机制的精神障碍,有几种仍在发展中的理论可以解释。在选择正确的治疗方法时,了解这些理论很重要,因为它增加了治疗成功的机会。目前正在开发各种策略,以便我们能够在某种程度上使治疗适应患者的个人需求,从而优化治疗效果并将副作用降到最低。个性化治疗的问题转化为医患之间更好的合作。在治疗过程中,就像治疗其他精神障碍一样,这两个部分的参与对其有效性至关重要。我们现有的治疗方法在减少精神分裂症的负面症状或认知障碍方面仍然没有产生令人满意的结果。目前,不仅精神病学的发展,而且与医学有关的某些科学分支的发展,如药物遗传学和分子生物学,都有助于取得令人满意的研究成果。因此,寻求新的治疗策略似乎是合理的。简要介绍最有前途的治疗方法是这篇文献综述的目的。它涵盖了药物治疗(卡吡嗪,鲁拉西酮,lumateperone, palperidone),经颅磁刺激(TMS),心理治疗和认知增强治疗(CET)。精神分裂症的药物遗传学问题也被提出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Omówienie wybranych metod współczesnej terapii schizofrenii
Schizophrenia is a mental disorder with a complex etiopathogenesis explained by several still developing theories. Knowledge of these theories can matter when choosing the right treatment, because it increases the chance of therapeutic success. Various strategies are currently being developed so that we can, to some extent, adapt therapy to the individual needs of patients and, thus, optimize the therapeutic effect and minimize side effects. The issue of personalization of therapy translates into better cooperation between the doctor and the patient. The involvement of both parts in the treatment process, as in the treatment of other mental disorders, is crucial for its effectiveness. The therapeutic methods that we have at our disposal are still not producing satisfactory results in reducing the negative symptoms or cognitive disorders that occur in schizophrenia. Currently, not only the development of psychiatry but also development of certain branches of science related to medicine, such as pharmacogenetics and molecular biology, can contribute to achieving satisfactory research results. It therefore seems reasonable to seek new treatment strategies. A brief presentation of the most promising therapeutic methods is the aim of this literature review. It covers pharmacological treatment (cariprazine, lurasidone, lumateperone, paliperidone), transcranial magnetic stimulation (TMS), psychotherapy and cognitive enhancement therapy (CET). The issue of pharmacogenetics of schizophrenia was also raised.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychiatria
Psychiatria Medicine-Psychiatry and Mental Health
CiteScore
0.60
自引率
0.00%
发文量
0
期刊介绍: "Psychiatry" is a quaternary journal addressed to professionals coming from all branches of psychiatry practicing in both hospital and outpatients departments. "Psychiatry" issues original articles, reviews, case reports, commentaries, and translated articles from leading journals in the field of psychiatry. The papers are reviewed by the members of the editorial board. "Psychiatry" also publishes the practice guidelines in sexology. Psychopharmacotherapy is the main field of interests of the quatrernary.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信